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Abstract: Severe sepsis occurs frequently in the intensive care unit (ICU) and is a leading cause of 
admission, mortality, and cost. Treatment guidelines recommend early intervention, however gold 
standard blood culture test results may return in up to 48 hours. Insulin sensitivity (SI) is known to 
decrease with worsening condition and inflammatory response, and could thus be used to aid clinical 
treatment decisions. Some glycemic control protocols are able to accurately identify SI in real-time. 
A biomarker for severe sepsis was developed from retrospective SI and concurrent temperature, heart 
rate, respiratory rate, blood pressure, and SIRS score from 36 adult patients with sepsis. Patients were 
identified as having sepsis based on a clinically validated sepsis score (ss) of 2 or higher (ss = 0–4 for 
increasing severity). Kernel density estimates were used for the development of joint probability density 
profiles for ss ≥ 2 and ss < 2 data hours (213 and 5858 respectively of 6071 total hours) and for 
classification. From the receiver operator characteristic (ROC) curve, the optimal probability cutoff 
values for classification were determined for in-sample and out-of-sample estimates. 
A biomarker including concurrent insulin sensitivity and clinical data for the diagnosis of severe sepsis 
(ss ≥ 2) achieves 69–94% sensitivity, 75–94% specificity, 0.78–0.99 AUC, 3–17 LHR+, 0.06–0.4 LHR-, 
9–38% PPV, 99–100% NPV, and a diagnostic odds ratio of 7–260 for optimal probability cutoff values 
of 0.32 and 0.27 for in-sample and out-of-sample data, respectively. The overall result lies between these 
minimum and maximum error bounds. Thus, the clinical biomarker shows good to high accuracy and 
may provide useful information as a real-time diagnostic test for severe sepsis. 
Keywords: sepsis, insulin sensitivity, model-based control, non-parametric, classification, characteristic 
curves, discrimination, likelihood, accuracy, decision support systems 
1. INTRODUCTION 
 
Severe sepsis is a serious medical condition characterized by 
systemic inflammatory response syndrome (SIRS) and organ 
failure due to infection (Bone et al. 1992). In the adult 
intensive care unit (ICU), severe sepsis has an 11–15% 
incidence, 30–60% mortality rate, $22,100 USD average cost 
per case, $16.7 billion USD annual total cost, and 1.5% 
projected annual increase (Angus et al. 2001). Current sepsis 
management guidelines recommend treatment within 6 hours 
of confirmed infection (Levy et al. 2003). However, gold 
standard blood culture diagnostic test results return in 24–48 
hours, by which time a serious complication may develop. 
Early treatment has been reported to reduce mortality from 
46.5% to 30.5% (Rivers et al. 2001). Alternative diagnostic 
tests based on identifying potential molecular markers for 
sepsis have not yet demonstrated sufficient performance to be 
routinely used in clinical practice (Pierrakos & Vincent 
2010). Thus, there remains a serious need for fast and 
accurate severe sepsis diagnostic tests. 
Model-based insulin sensitivity (SI) has been observed to 
indicate the severity of illness, decrease with worsening 
condition (Chambrier et al. 2000), and increase with 
improvement (Chase et al. 2008; Langouche et al. 2007). A 
clinically validated glucose-insulin physiological model that 
is able to identify hourly SI has been used to develop blood 
glucose control management protocol for critically ill patients 
(Chase et al. 2007). 
Previous work has shown model-based hourly SI as a 
potential biomarker for septic shock (Blakemore et al. 2008). 
A biomarker including hourly SI and available bedside 
clinical data has differentiated severe sepsis in a cohort of 
adult ICU patients (Lin et al. 2010). Thus, model-based SI in 
combination with clinical measurements offers unique 
potential for early, rapid detection of severe sepsis or sepsis 
shock in clinical “real-time”. 
This outcome can be achieved by creating a classification 
method to identify an unknown patient hour as severe sepsis 
or non-severe sepsis. Thus, a method utilising kernel density 
estimates to develop joint density profiles for severe sepsis 
and non-severe sepsis and for classification is presented. 
Standard diagnostic test performance outcomes (Fischer et al. 
2003) are reported to evaluate the SI and clinical biomarker 
joint density diagnostic test performance, as compared to the 
clinically validated patient sepsis score. 
 
  
     
 
2. METHODS 
 
Retrospective clinical data including hourly insulin 
sensitivity, temperature, heart rate, respiratory rate, blood 
pressure, and SIRS score were collected from adult sepsis 
patients.  Kernel density estimates were used for the 
development of joint probability density profiles for severe 
sepsis and non-severe sepsis hours and for classification.  
Diagnostic test properties were analyzed by comparing test 
outcomes to a clinically validated sepsis score (ss). 
2.1  Sepsis score (ss) and cohort 
Severe sepsis is a systemic inflammatory response syndrome 
(SIRS) and organ failure due to infection (Bone et al. 1992). 
Patient sepsis score is defined by ACCP/SCCM guideline 
definitions (Levy et al. 2003). The defined criteria include 
SIRS and the Sepsis-related Organ Failure Assessment 
(SOFA) score (Vincent et al. 1996) found in Appendix A. 
Clinical data was obtained from n = 36 sepsis patients 
admitted to the medical ICU in Christchurch Hospital. Each 
patient was on the SPRINT blood glucose control protocol 
(Chase et al. 2008), providing 9286 total patient hours of 
model-based hourly SI. Additional clinical data collected 
includes: temperature, heart rate, respiratory rate, blood 
pressures, and SIRS score. Patient hours were removed if any 
of these concurrent clinical data were not reported on the 
medical record. Data hours that are unambiguously without 
infection (i.e., ss = 0 and SIRS < 2) were removed, providing 
a new total of 6071 hours of data useful for developing and 
testing the classifier. Notably, each sepsis patient had 
episodes both with sepsis (ss ≥ 1) and non-sepsis (ss = 0). 
Thus, each patient provides periods of control to changes in 
their physiological condition and sepsis score (ss = 0–4).   
Cohorts are defined as severe sepsis (ss ≥ 2) and non-severe 
sepsis (ss < 2). Notably, this study includes particular patient 
hours which are normally omitted in other studies, as they 
cannot be classified unambiguously (Kuster et al. 1998). 
Such omissions would have resulted in a case-control design. 
Case-control design has been identified as the most important 
source of bias for overestimating test accuracy (Lijmer et al. 
1999). Importantly, no such omissions are made in this study. 
The clinical reality of early sepsis management in the ICU 
deviates from the use of blood culture alone as an absolute 
gold standard. Rather, the gold standards clinicians use are 
confirmed infection with clinical evidence and unconfirmed 
infection without clinical evidence. Most clinicians are able 
to distinguish between a severely ill patient and a healthy 
control. However, clinicians seek help for exactly the 
ambiguous cases. Thus, this set of data provides hour to hour 
evaluation of the SIRS/SS/SOFA score, as an effective 
objective gold standard to test the diagnostic ability of the 
developed classification system. 
Figures 1–5 provide raw data in a discrete form consistent 
with original patient medical records and normalized to the 
cohort size. Each data set has a sum of 1. When applicable, 
relevant SIRS and SOFA classification criteria definitions are 
shown. 
 
Fig. 1. Model-based insulin sensitivity (SI) raw data, grouped 
by severe sepsis and non-severe sepsis cohorts. 
 
Fig. 2. Temperature raw data. One of the SIRS criteria is 
temperature < 36° C or > 38° C. 
 
Fig. 3. Heart rate raw data. One of the SIRS criteria is heart 
rate > 90 beats/min. 
  
     
 
 
Fig. 4. Respiratory rate raw data.  One of the SIRS criteria is 
respiratory rate > 20 breaths/min or mechanically ventilated. 
 
Fig. 5. Mean arterial pressure (MAP) raw data. One of the 
SOFA criteria is MAP < 60 mm Hg. 
It can be observed that between severe sepsis and non-severe 
sepsis cohorts, SI and respiratory rate decrease with increased 
ss, while heart rate and mean arterial pressure increase, and 
temperature remains undistinguished between cohorts. Thus, 
some clinical data may contribute more strongly to 
discriminating patient sepsis states. 
2.2  Classification 
Kernel density estimates can be used for classification and 
identification of potential diagnostic biomarkers (Moorhead 
et al. 2008). Clinically validated sepsis scores at each patient 
hour are used to develop probability density profiles for each 
of the two data sets: Groups j and k, for each clinical 
predictor. In this diagnostic analysis, j and k would be the 
severe sepsis (ss ≥ 2) and non-severe sepsis (ss < 2) data. A 
patient hour is then tested against the established datasets, 
with the result being a classification into either Group j or k. 
For each given patient hour, the joint probability density for 
Groups j and k of each clinical predictor are compared. Log 
transforms were used to remove natural data bounds from 
model-based SI, respiratory rate, diastolic blood pressure, and 
SIRS. 
Let x0 denote the value of a single clinical predictor at the 
given hour, and  and  denote the joint probability 
densities of Group j and k, respectively, at the clinical 
predictor values at that hour.  Thus, for a given hour of 
clinical data, the joint probability density of these data being 
from a severe sepsis or non-severe sepsis cohort is compared 
for classification. 
For each hour, the probability of the given data value being 
from Group j, given the data value obtained at that hour is x0 
is defined 
 (1) 
 
where  is the prior probability of the sample being in that 
group. In this case, the prior probabilities are set to 0.5, as no 
reliable historical information of the prior probability for 
these cohorts is known. Thus, the prior probability does not 
impact classification. If the ratio in (1) is greater than a 
specified probability threshold, then the sample is classified 
as being in the numerator (Group j), otherwise it is classified 
as being in Group k. 
As well as classification, an estimate of prediction error is 
required. In-sample estimates and out-of-sample estimates 
using the stratified bootstrap method (take out 20% to test 
against) and 1000 bootstraps were used to estimate the 
classification model prediction minimum and maximum error 
bounds, respectively. 
2.3  Sensitivity and specificity 
Standard diagnostic test properties are reported as 
recommended by Fischer et al. (2003). An optimal 
probability cutoff value was obtained from the receiver 
operator characteristic (ROC) curve, which best discriminates 
severe sepsis (ss ≥ 2) and non-severe sepsis (ss < 2) cohorts. 
A contingency matrix is used to provide sensitivity and 
specificity with respect to a clinically validated sepsis score. 
2.4  Predictive values and likelihood ratios 
Likelihood ratios and predictive values provide the 
probability that a patient with a given test result is actually 
infected (Jaeschke et al. 1994a; Jaeschke et al. 1994b). 
Predictive values represent the proportion of test results 
which correctly identify severe sepsis, positive predictive 
value (PPV), and non-severe sepsis, negative predictive value 
(NPV). Note that the major determinant of the predictive 
value is the infection prevalence (Smith et al. 2000). 
An alternative method to assess the predictive properties of a 
test is the likelihood ratio (Jaeschke et al. 1994a). Likelihood 
ratios are independent from prevalence. The likelihood ratio 
is the ratio of the probability that a specific test result is 
obtained in patients with severe sepsis divided by the 
probability of obtaining the same test result in non-severe 
sepsis patients (Fischer et al. 2003). 
  
     
 
The likelihood ratio for a positive test result (LHR+) could be 
calculated as 
. (2) 
 
The likelihood ratio for a negative test result (LHR-) is 
obtained as 
. (3) 
 
Multilevel likelihood ratios (MLR) are also presented to 
allow which levels of test results yield clinically important 
information, and which levels of test results do not (Jaeschke 
et al. 1994b). 
2.5  The receiver operator characteristic curve and the 
diagnostic odds ratio 
A single measure that summarizes the discriminative ability 
of a test across the full range of probability cutoff values, and 
is also independent of prevalence, is the area under the ROC 
(AUC). Reporting AUCs allows valuable statistical 
comparison of diagnostic tests (Hanley & McNeil 1983). It is 
particularly useful if applied to the same patient population 
for the same diagnostic question. 
Finally, an alternative way to compare tests that is also 
relatively independent of prevalence is by means of the 
diagnostic odds ratio (Lijmer et al. 1999). The diagnostic 
odds ratio (DOR) is calculated as 
. (4) 
 
3. RESULTS AND DISCUSSION 
3.1  Sepsis score (ss) and cohort 
The prevalence of severe sepsis (ss ≥ 2) is 3.5% (213 hours of 
the 6071 total hours) in the data collected for this study. Such 
a low prevalence is clinically realistic throughout sepsis 
patient hourly data. Table 4 shows the prevalence for each ss 
value. 
Table 4. Sepsis score (ss) prevalence for original and 
filtered (removed ss = 0 when SIRS < 2) data 
ss 0 1 2 3 4 
original 
4186 
(45.1%) 
4861 
(52.4%) 
91 
(1.0%) 
88 
(1.0%) 
60 
(0.7%) 
filtered 
1558 
(25.7%) 
4300 
(70.8%) 
85 
(1.4%) 
79 
(1.3%) 
49 
(0.8%) 
3.2  Sensitivity and specificity 
The optimal probability cutoff values for the kernel classifier 
are 0.32 and 0.27 for in-sample and out-of-sample estimates, 
respectively. The optimal cutoff value has important bearing 
on the following measures of test accuracy. The ROC curves 
are shown in Figure 6. The contingency matrices are shown 
on Tables 5 and 6. 
 
Fig. 6. ROC curves for the joint density kernel classifier, with 
optimal probability cutoff values shown. The overall 
performance lies between these maximum error bounds. 
Table 5. Contingency matrix for in-sample estimates 
(total 6071 hours) 
cutoff 
0.32 
ss ≥ 2 
213 hours 
ss < 2 
5858 hours 
prevalence 
3.5% 
test positive 
527 hours 
TP = 200 
(3.3%) 
FP = 327 
(5.4%) 
PPV 
38% 
test negative 
5544 hours 
FN = 13 
(0.2%) 
TN = 5531 
(91.1%) 
NPV 
100% 
   
sensitivity 
94% 
specificity 
94% 
AUC 
0.99 
log odds 
ratios 
LHR+ 
17 
LHR- 
0.06 
DOR 
260 
 
Table 6. Contingency matrix for out-of-sample estimates 
(1000 bootstraps, total 1,215,000 hours) 
cutoff 
0.27 
ss ≥ 2 
43,000 
hours 
ss < 2 
1,172,000 
hours 
prevalence 
3.5% 
test positive 
326,337 
hours 
TP = 29,817 
(2.5%) 
FP = 
296,520 
(24.4%) 
PPV 
9% 
test negative 
888,663 
hours 
FN = 13,183 
(1.1%) 
TN = 
875,480 
(72.1%) 
NPV 
99% 
 
sensitivity 
69% 
specificity 
75% 
AUC 
0.78 
log odds 
ratios 
LHR+ 
3 
LHR- 
0.4 
DOR 
7 
 
The test performs with 69%–94% sensitivity and 75–94% 
specificity. The overall result lies between these maximum 
estimate bounds. The kernel classifier correctly identifies the 
majority of ss ≥ 2 and ss < 2 patient hours. 
  
     
 
3.3  Predictive values and likelihood ratios 
The test has 9–38% PPV and 99–100% NPV. The majority of 
negative outcomes are from true negative (TN) patient hours. 
PPV is low due to the low disease prevalence (3.5%). 
However, the low ratio of ss ≥ 2 to ss < 2 is clinically 
realistic for hour to hour data during patient length of stay. 
The major determinant of predictive values is the prevalence 
of infection (Smith et al. 2000). Thus, predictive values 
depend not only on the test’s properties, but also on the 
prevalence of disease in the population. Therefore they do not 
represent the test’s inherent accuracy by themselves. 
The test performs with 3–17 LHR+ and 0.06–0.4 LHR-. This 
can be interpreted to mean that the probability of obtaining an 
in-sample probability greater than 0.32 is obtained 
approximately 17 times more often from a patient with ss ≥ 2 
than from a patient with ss < 2. A likelihood value of 1 
implies the test result is equally likely to occur among 
patients with the disease as in patients without the disease. 
Tests with LHR+ > 10 or LHR- <  0.1 have the potential to 
alter clinical decisions (Jaeschke et al. 1994b). Tests with 5–
10 LHR+ or 0.1– 0.2 LHR- often provide useful information. 
Tests with LHRs ranging from 0.33–3 rarely alter clinical 
decisions. Thus, this test may have the potential to alter 
clinical decisions for the positive identification of severe 
sepsis. This test may also provide useful additional 
information for determining non-severe sepsis. 
MLR results across the range of probability cutoff values 
within sensitivity or specificity > 95% are shown in Table 7. 
Note the ROC probability cutoff values start from 0 at the top 
right corner of Figure 6. The disadvantage of dichotomizing 
test results is that useful information may be lost, as a test 
result returned may be negative, indeterminate, or positive. 
3.4  The receiver operator characteristic curve and the 
diagnostic odds ratio 
The ROC curves have 0.78–0.99 AUC. Perfect tests yield an 
AUC of 1.0. A test with an AUC > 0.9 has high accuracy, 
while 0.7–0.9 indicates moderate accuracy, 0.5–0.7 low 
accuracy, and 0.5 a chance result (Swets 1988). Therefore, 
this test performs with good to high accuracy. 
For tests with intermediate to good discriminative properties 
(0.75–0.85 AUC), the curve shape requires consideration. 
Accepting a margin of error of 5% (sensitivity or specificity 
> 95%), curve probability cutoff values in the ROC upper 
horizontal rectangle are useful to rule-in infection, while 
points on the curve in the ROC left, vertical rectangle assist 
in ruling-out infection in Figure 6. 
Probability values from 0–0.29 and 0–0.02 rule in infection, 
while probability values from 0.33–1 and 0.71–1 rule out 
infection for in-sample and out-of-sample estimates, 
respectively. These values define the range of probability 
values shown in the MLR in Table 7.  
The test yields 7–260 DOR for the optimal probability cutoff 
values. Potentially useful tests have DOR >  20 (Fischer et al. 
2003). Thus, this test may be potentially useful. 
Table 7. Multilevel likelihood ratios (MLR) 
 cutoff value LHR+ LHR- DOR 
in- 
sample 
0.29 13 0.06 226 
0.32 17 0.06 260 
0.33 18 0.07 244 
out-of- 
sample 
0.02 1 0.2 5 
0.27 3 0.4 7 
0.5 5 0.6 9 
0.71 7 0.7 10 
 
4. CONCLUSIONS 
Joint kernel density estimates for insulin sensitivity and 
concurrent clinical data, including temperature, heart rate, 
respiratory rate, blood pressure, and SIRS score provide a 
good to highly accurate diagnostic test for severe sepsis (ss ≥ 
2). Some clinical data may contribute more strongly to 
patient diagnosis. At an optimal probability cutoff value for 
in-sample and out-of-sample estimates, the diagnostic test 
correctly classifies the majority of ss ≥ 2 and ss < 2 hours. 
Low PPV and high NPV are due to the low prevalence 
(3.5%) of ss ≥ 2 in the hourly data from a cohort where case-
control design has been avoided. LHR and the AUC 
demonstrate that this test provides potentially useful 
information and may have the potential to alter clinical 
decisions towards severe sepsis diagnosis. 
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 Appendix A. SEPSIS SCORE CRITERIA 
Table 1. SIRS criteria 
score criteria 
+ 1 temperature 
< 36º C 
> 38º C 
+ 1 heart rate > 90 beats/min 
+ 1 
respiratory rate 
or PaCO2 
> 20 breaths/min 
< 32 mm Hg 
+ 1 
white blood 
cell count 
< 4 x 109/L or > 12 x 109/L or 
> 10% immature granulocytes 
Table 2. SOFA criteria 
score system criteria 
+ 1 cardiovascular 
MAPa or 
need for 
inotropes 
< 60 mm Hg 
+ 1 respiratory PaO2/FiO2 
<250 mm Hg/mm Hg 
<200 mm Hg/mm Hg 
with pneumonia 
+ 1 renal urine output < 0.5 ml/kg/h 
+ 1 blood platelets 
< 80 x 109/L or 50% 
drop in 3 days 
aMean arterial pressure 
Table 3. Sepsis score (ss) criteria 
sepsis score SIRS > 2 
infection 
during stay 
organ failure > 1 
fluid 
resuscitation 
inotrope 
present 
inotrope dose 
> 0.2 mg min-1 kg-1 
0 normal       
1 sepsis X X     
2 severe sepsis X X X X   
3 septic shock X X X X X  
4 
refractory septic 
shock 
X X X X X X 
 
